BPC157 & TB500 32 Pen
Pre-filled research pen containing 16mg BPC-157 and 16mg TB-500 (Thymosin Beta-4 Acetate). For research purposes only.
BodyPharm UAE supplies BPC157 & TB500 32 Pen for research purposes across Dubai, Abu Dhabi, Sharjah, and the wider UAE. All compounds are sourced to strict purity standards and shipped with secure, trackable delivery.
Research Areas
Designed for advanced research in these areas
Musculoskeletal tissue repair mechanisms
Inflammatory pathway modulation
Gastrointestinal cytoprotection studies
Post-injury tissue remodelling research
Certificate of Analysis
Verified by independent & in-house laboratory testing
Janoshik Analytical
Third-party laboratory
Report
#106569
Batch
BCTB0178
Purity
99.13% / 99.36%
Sample
32mg pen 3ml
In-House Testing
Body Pharm laboratory
Report
#250710
Batch
BCTB0178
Purity
TB: 99.13% BPC: 99.36%
Concentration
5.4 mg/ml
Precision Engineered
This dual-peptide formulation combines BPC-157, a pentadecapeptide originally isolated from gastric juice and studied for its role in tissue-protective signalling, with TB-500 (Thymosin Beta-4 fragment), a synthetic peptide investigated for its involvement in cell migration, angiogenesis, and wound-repair pathways. The combination is of particular interest in research exploring synergistic tissue-repair mechanisms.
Frequently Asked Questions
BPC-157 + TB-500 is a dual-peptide research formulation combining Body Protection Compound-157 (a pentadecapeptide derived from gastric juice protein) and TB-500 (synthetic Thymosin Beta-4 analogue). Both compounds are subjects of ongoing preclinical research into tissue repair signalling, angiogenesis, and extracellular matrix remodelling. BodyPharm supplies this formulation strictly for laboratory research purposes.
BodyPharm sells BPC-157 + TB-500 strictly for research purposes. Customers are responsible for understanding applicable regulations in their jurisdiction.
Preliminary findings from preclinical studies suggest BPC-157 may interact with nitric oxide signalling, growth factor pathways, and wound-healing transcription factors. Research on TB-500 indicates involvement in actin polymerisation dynamics and cellular migration. These findings are from laboratory and animal models and have not been confirmed in human clinical trials.
Research interest in combining BPC-157 and TB-500 stems from their potentially complementary mechanisms. BPC-157 is studied for growth factor modulation and TB-500 for cytoskeletal dynamics. Studies indicate these pathways may be distinct but overlapping in tissue remodelling models. BodyPharm supplies this combination exclusively for qualified laboratory investigation.
BodyPharm is a UAE-based research peptide supplier offering BPC-157 + TB-500 for laboratory use with same-day delivery across Dubai, Abu Dhabi, and the wider UAE. All batches are independently verified at 99% or higher purity by Janoshik analytical laboratory.
Research-grade BPC-157 + TB-500 should be stored refrigerated at 2 to 8 degrees Celsius in a controlled laboratory environment. Exposure to heat or light should be minimised to maintain compound stability.
What Researchers Say
How was our customer service? Did your delivery arrive on time? Was the product what you expected? Let us know and receive 10% off and free delivery with your next order.
Specifications
Premium-grade formulation for advanced research
32mg
Total Content
≥99%
Purity
Pre-filled Research Pen
Format
2-8°C Refrigerated
Storage
0.25mg, 0.5mg, 0.75mg, 1mg
Volume Options
BPC-157 & TB-500
Active Ingredient
Ready to order?
BPC157 & TB500 32 Pen
AED 850
Same day delivery across the UAE